Role of p53 in the Regulation of Cellular Senescence
Open accessThe DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
The p53 transcription factor plays a critical role in cellular responses to stress. Its activation in response to DNA damage leads to cell growth arrest, allowing for DNA repair, or directs cellular senescence or apoptosis, thereby maintaining genome integrity. Senescence is a permanent cell-cycle arrest that has a crucial role in aging, and it also represents a robust physiological antitumor response, which counteracts oncogenic insults. In addition, senescent cells can also negatively impact the surrounding tissue microenvironment and the neighboring cells by secreting pro-inflammatory cytokines, ultimately triggering tissue dysfunction and/or unfavorable outcomes. This review focuses on the characteristics of senescence and on the recent advances in the contribution of p53 to cellular senescence. Moreover, we also discuss the p53-mediated regulation of several pathophysiological microenvironments that could be associated with senescence and its development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Induction and initiation of cellular growth control and senescence via p53 or P16INK4A pathways. Various internal or external stress factors trigger the DNA-damage response (DDR) pathway, which in turn activates the p53 and/or the p16INK4A pathways. p16INK4A inactivates Cdk4/6, results in accumulation of phosphorylated pRb, stops the regulation of E2F transcription factors, and drives cell cycle arrest or senescence. These stressors also trigger DNA damage (cellular responses to such damages are regulated by either ATM-Chk2 or ATR-Chk1 pathways) and transactivate p53 and p21CIP1. Moreover, p21CIP1 protein levels may lead to the inhibition of Cdk4/6 activity, which contribute to the G1 arrest or senescence [33,34].](https://figures.cochat.ai/paper-figures/73d1c8e4b31243a49a8fdf24b567946a/role-of-p53-in-the-regulation-of-cellular-senescence-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Senescence is driven by the tumor-suppressor pathways p53-p21CIP1 and p16INK4a-Rb,19,20,21”
From Cellular senescence in human liver under normal aging and cancer (2026) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“with CDKN2A (p16INK4a) and CDKN1A (p21CIP1) serving as canonical senescence markers.”
From Cellular senescence in human liver under normal aging and cancer (2026) · cites this paper as [19]
In the citing paper
“The p16INK4A/Rb pathway also plays a critical role in senescence. CDK4/6 are inactivated by p16INK4A, promoting the accumulation of phosphorylated Rb and the inactivation of E2F transcription, which induces senescence.66”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [66]
In the citing paper
“p16INK4A inactivates Cdk4/6, phosphorylates Rb accumulation and inactivates E2F transcription, leading to cell cycle arrest or senescence.85”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [85]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 1×
“Cellular senescence is a physiological mechanism adopted by cells to limit tumorigenesis [99,100], and for this reason, a therapy-induced senescence was considered as an alternative and possibly safer approach to the traditional cancer therapy, which aimed at inducing extensive DNA damage [101].”
BackgroundInflammatory responses and inflammation-associated diseases in organs
Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2018) · Oncotarget · doi:10.18632/oncotarget.23208 · Cited by 5,143 · cited 1×
“It is responsible for many chronic diseases, including cardiovascular and bowel diseases, diabetes, arthritis, and cancer [114,115].”
BackgroundIn Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · cited 2×
“Many recent studies actually demonstrated how many OIS pathways can actually activate p53 bypassing the DDR: Ras through NOREA1, which promotes the pro-senescence acetylation of p53 while inhibiting its pro-apoptotic phosphorylation, AKT through the downregulation of MnSOD, onco-suppressor PTEN depletion, inducing mTO…”
BackgroundCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 2×
“Cellular senescence is defined as a cell state characterized by prolonged and generally irreversible cell-cycle arrest [14] and the acquisition of different phenotypic alterations, including morphological changes, chromatin remodeling, metabolic reprogramming, and secretion of pro-inflammatory factors or SASP (senesce…”
BackgroundBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · cited 1×
“This impressive number is a reflection of the many—sometimes alternative—roles p53 can play; in fact, several of these genes are known to be involved in the regulation of metabolism, autophagy, DNA damage repair, cell cycle arrest, quiescence, senescence, and apoptosis [35].”
BackgroundThe role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379 · cited 1×
“However, once p16 is highly expressed, downregulation of p53 cannot reverse cell cycle arrest [58].”
BackgroundCellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“Stressors include both intrinsic factors, such as oxidative damage, telomere attrition, hyperproliferation, oncogene activation, and environmental sources, including UV-light, γ-irradiation, and chemotherapeutic drugs [18,19].”
BackgroundOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086 · cited 1×
“They also reported co-localization of IL-8 and senescence markers in human colon adenomas [42].”
BackgroundThe essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038 · cited 2×
“He observed a phenomenon of “replicative senescence” in cultures of non-immortalized human fibroblasts and described it as the exhaustion and/or the termination of proliferative capacity of primary cells in culture [2].”
BackgroundKastenhuber, E. R., & Lowe, S. W. (2017) · Cell · doi:10.1016/j.cell.2017.08.028 · Cited by 1,906 · cited 1×
“Recently, increasing interest has focused on the role of p53 in the regulation of cellular growth induced by intense oncogenic signals or replicative stress [10].”
BackgroundRestoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820 · cited 1×
“It was reported that reactivation of p53 in tumors provokes tumor regression mediated by induction of senescence [103].”
BackgroundReversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457 · cited 2×
“, for a late senescent state characterized by a distinct and permanent senescence phenotype, which is no longer reversible through p53 inhibition [53].”
BackgroundClearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Bussian, T. J., Aziz, A., Meyer, C. F., Swenson, B. L., van Deursen, J. M., & Baker, D. J. (2018) · Nature · doi:10.1038/s41586-018-0543-y · Cited by 1,289 · cited 1×
“reported an accumulation of p16INK4A positive senescent astrocytes and microglia in a mouse model of tau-dependent neurodegenerative disease, and the clearance of senescent glial cells prevented tau-dependent pathology and cognitive decline [128].”
BackgroundMechanisms and functions of cellular senescence
Herranz, N., & Gil, J. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95148 · Cited by 1,232 · cited 2×
“These latter count cytokines, growth factors, proteases, and non-soluble extracellular matrix proteins [15].”
BackgroundSenescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 1×
“Cellular senescence is a physiological mechanism adopted by cells to limit tumorigenesis [99,100], and for this reason, a therapy-induced senescence was considered as an alternative and possibly safer approach to the traditional cancer therapy, which aimed at inducing extensive DNA damage [101].”
BackgroundForging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“The most extensively studied pathways involved in the regulation of cellular senescence are p53/p21cip1 and/or p16INK4A/Rb tumor suppressor pathways [29,30] (Figure 1).”
BackgroundSteffan, J. S., Kazantsev, A., Spasic-Boskovic, O., Greenwald, M., Zhu, Y.-Z., Gohler, H., Wanker, E. E., Bates, G. P., Housman, D. E., & Thompson, L. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100110097 · Cited by 1,062 · cited 1×
“senescence involved in the striatum during HD development [85,86]”
BackgroundUnmasking Transcriptional Heterogeneity in Senescent Cells
Hernandez-Segura, A., de Jong, T. V., Melov, S., Guryev, V., Campisi, J., & Demaria, M. (2017) · Current Biology · doi:10.1016/j.cub.2017.07.033 · Cited by 972 · cited 1×
“Additionally, while a significant contribution to this heterogeneity was shown to be dependent on the different types of cells, time-series transcriptomic profiling studies also showed the expression of different genes at different times [64].”
BackgroundCensus and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971 · cited 2×
“tried to take a census of these genes and proposed approximately 3661 potential p53 targets [11].”
BackgroundSenescence and apoptosis: dueling or complementary cell fates?
Childs, B. G., Baker, D. J., Kirkland, J. L., Campisi, J., & van Deursen, J. M. (2014) · The EMBO Reports · doi:10.15252/embr.201439245 · Cited by 915 · cited 1×
“Similar results were found in an in vitro study [111], where the blood flow-induced mechanical forces determined arterial injury and promoted endothelial senescence via p53-p21cip1-dependent pathways [112].”
Resultp53 in the DNA–Damage–Repair Process
Williams, A. B., & Schumacher, B. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026070 · Cited by 835
Cellular senescence and tumor suppressor gene p16
Rayess, H., Wang, M. B., & Srivatsan, E. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27316 · Cited by 825 · cited 1×
“While the p53/p21cip1 pathway seems to play a key role in the initiation of senescence, the pathway involving p16 and the retinoblastoma family of proteins (Rb family) seems to have a central role in the maintenance of senescence [2,51].”
BackgroundSenescence and aging: the critical roles of p53
Rufini, A., Tucci, P., Celardo, I., & Melino, G. (2013) · Oncogene · doi:10.1038/onc.2012.640 · Cited by 798 · cited 1×
“p21cip1 is the founding member of the mammalian CDK inhibitor family and, as such, it is required for the p53-induced cell cycle arrest at either G1/S or G2/M checkpoints [43,44].”
BackgroundExosomes maintain cellular homeostasis by excreting harmful DNA from cells
Takahashi, A., Okada, R., Nagao, K., Kawamata, Y., Hanyu, A., Yoshimoto, S., Takasugi, M., Watanabe, S., Kanemaki, M. T., Obuse, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15287 · Cited by 761
Tian, T., Wang, Z., & Zhang, J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4535194 · Cited by 714 · cited 1×
“It is responsible for many chronic diseases, including cardiovascular and bowel diseases, diabetes, arthritis, and cancer [114,115].”
BackgroundThe dynamic nature of senescence in cancer
Lee, S., & Schmitt, C. A. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0249-2 · Cited by 588 · cited 2×
“senescence”, where cells are poised to demonstrate full-featured senescence [62].”
BackgroundThe role of p53 in cancer drug resistance and targeted chemotherapy
Hientz, K., Mohr, A., Bhakta-Guha, D., & Efferth, T. (2017) · Oncotarget · doi:10.18632/oncotarget.13475 · Cited by 587 · cited 2×
“p53-dependent upregulation of p21cip1 leads to dysregulation of DNA replication and has been reported in aggressive cancer cells [101].”
BackgroundCellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives
Baker, D. J., & Petersen, R. C. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95145 · Cited by 514 · cited 1×
“demonstrated the presence of senescent microglial cells and astrocytes in their experimental mice of neurodegenerative disease and evidenced how such cells led to neurodegenerative diseases and memory problems [124].”
BackgroundMarkers of cellular senescence. Telomere shortening as a marker of cellular senescence
Bernadotte, A., Mikhelson, V. M., & Spivak, I. M. (2016) · Aging · doi:10.18632/aging.100871 · Cited by 466 · cited 1×
“Replicative senescence has been linked to progressive telomere shortening, a physiological function occurring every time the cell divides and which has been associated with the activation of specific molecular pathways [3,4].”
BackgroundAgeing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448 · cited 1×
“This form of senescence is also known as stress-induced premature senescence (SIPS) and has broad implications in health and diseases [8,9].”
BackgroundCellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
Palmer, A. K., Tchkonia, T., LeBrasseur, N. K., Chini, E. N., Xu, M., & Kirkland, J. L. (2015) · Diabetes · doi:10.2337/db14-1820 · Cited by 423 · cited 1×
“Metabolic and signaling changes seen in diabetes, such as high circulating glucose, altered lipid metabolism, and growth hormone axis perturbations, can promote senescent cell formation [108].”
BackgroundTelomeres and cell senescence—size matters not
Victorelli, S., & Passos, J. F. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.027 · Cited by 413
Redox control of senescence and age-related disease.
Chandrasekaran, A., Idelchik, M. D. P. S., & Melendez, J. A. (2017) · Redox Biology · doi:10.1016/j.redox.2016.11.005 · Cited by 360
Hallmarks of senescence and aging
Dodig, S., Čepelak, I., & Pavić, I. (2019) · Biochemia medica · doi:10.11613/bm.2019.030501 · Cited by 344 · cited 1×
“Cellular senescence has been implicated not only in aging itself but also in the onset of age-related disorders, including atherosclerosis, diabetes, and Alzheimer’s disease, in cancer, and, more recently, in biological processes such as tissue repair and regeneration and homeostasis of the microenvironment [72,73].”
BackgroundCellular senescence: at the nexus between ageing and diabetes
Palmer, A. K., Gustafson, B., Kirkland, J. L., & Smith, U. (2019) · Diabetologia · doi:10.1007/s00125-019-4934-x · Cited by 337 · cited 1×
“Diabetes + hyperglycemia p53 contributes to insulin resistance; decreased islet proliferation [79,80]”
BackgroundVarious modes of cell death induced by DNA damage
Surova, O., & Zhivotovsky, B. (2013) · Oncogene · doi:10.1038/onc.2012.556 · Cited by 334 · cited 1×
“Mild DNA damage normally induces cell cycle arrest, while severe injury can activate the senescence program or the death programs; the latter includes apoptosis, mitotic catastrophe, autophagy, and necrosis [21].”
BackgroundCigarette smoke induces cellular senescence
Nyunoya, T., Monick, M. M., Klingelhutz, A., Yarovinsky, T. O., Cagley, J. R., & Hunninghake, G. W. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0169oc · Cited by 306 · cited 1×
“p53 activity decreases with time, and this is consistent with the idea of p53 (and p21cip1) being a crucial factor for the induction of the senescence and a gate to an early phase and still reversible senescence [68].”
BackgroundThe Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
Kreis, N.-N., Louwen, F., & Yuan, J. (2019) · Cancers · doi:10.3390/cancers11091220 · Cited by 298 · cited 1×
“The p53/p21cip1 axis in the context of cellular senescence has been implicated in several cancer types, including breast cancer, cholangiocarcinoma, head and neck squamous cell cancer, liver cancer, lung cancer, colorectal cancer, as well as ovarian cancer [102].”
BackgroundYosef, R., Pilpel, N., Papismadov, N., Gal, H., Ovadya, Y., Vadai, E., Miller, S., Porat, Z., Ben‐Dor, S., & Krizhanovsky, V. (2017) · The EMBO Journal · doi:10.15252/embj.201695553 · Cited by 293 · cited 1×
“p21cip1 knockout in senescent cells provokes programmed cell death through the caspase activation cascade [46].”
BackgroundDistinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate
Knights, C. D., Catania, J., Giovanni, S. D., Muratoglu, S., Perez, R., Swartzbeck, A., Quong, A. A., Zhang, X., Beerman, T., Pestell, R. G., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200512059 · Cited by 287 · cited 1×
“Acetylation in other sites leads to p53 hyperphosphorylation and therefore interaction with genes with low p53 affinity, such as pro-apoptotic genes [41].”
BackgroundEmerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence
Xu, Y., Li, N., Xiang, R., & Sun, P. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.04.004 · Cited by 282 · cited 1×
“Many recent studies actually demonstrated how many OIS pathways can actually activate p53 bypassing the DDR: Ras through NOREA1, which promotes the pro-senescence acetylation of p53 while inhibiting its pro-apoptotic phosphorylation, AKT through the downregulation of MnSOD, onco-suppressor PTEN depletion, inducing mTO…”
BackgroundCellular senescence and the aging brain
Chinta, S. J., Woods, G., Rane, A., Demaria, M., Campisi, J., & Andersen, J. K. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.018 · Cited by 282 · cited 3×
“Neurotoxic effects of astrocytes are mediated by SASP involving pro-inflammatory cytokine secretion (e.g., Il-6), while neuroprotection is mediated by neurotropic growth factors such as NGF [126].”
BackgroundInfluentialCHEN, Q. M., LIU, J., & MERRETT, J. B. (2000) · Biochemical Journal · doi:10.1042/bj3470543 · Cited by 280 · cited 1×
“They evidenced how, in induced apoptotic conditions, p53 levels were two times higher compared to p53 levels in growth arrest conditions [37].”
BackgroundSenescence, Apoptosis or Autophagy?
Vicencio, J. M., Galluzzi, L., Tajeddine, N., Ortiz, C., Criollo, A., Tasdemir, E., Morselli, E., Ben Younes, A., Maiuri, M. C., Lavandero, S., et al. (2008) · Gerontology · doi:10.1159/000129697 · Cited by 261
The Dual Role of Cellular Senescence in Developing Tumors and Their Response to Cancer Therapy
Schosserer, M., Grillari, J., & Breitenbach, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00278 · Cited by 259
Reversal of Senescence in Mouse Fibroblasts through Lentiviral Suppression of p53
Dirac, A. M. G., & Bernards, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300023200 · Cited by 255 · cited 1×
“Time-lapse photomicrographs showed that the cells reentering the cell cycle were originated from senescent cells [61].”
BackgroundMitochondrial Homeostasis and Cellular Senescence
Vasileiou, P., Evangelou, K., Vlasis, K., Fildisis, G., Panayiotidis, M., Chronopoulos, E., Passias, P.-G., Kouloukoussa, M., Gorgoulis, V., & Havaki, S. (2019) · Cells · doi:10.3390/cells8070686 · Cited by 244 · cited 1×
“DNA damage and /or DDR seem to critically control the two pathways [31,32].”
BackgroundAl Bitar, S., & Gali-Muhtasib, H. (2019) · Cancers · doi:10.3390/cancers11101475 · Cited by 224 · cited 1×
“p21cip1 is the founding member of the mammalian CDK inhibitor family and, as such, it is required for the p53-induced cell cycle arrest at either G1/S or G2/M checkpoints [43,44].”
BackgroundIonizing Radiation-Induced Endothelial Cell Senescence and Cardiovascular Diseases
Wang, Y., Boerma, M., & Zhou, D. (2016) · Radiation Research · doi:10.1667/rr14445.1 · Cited by 203 · cited 1×
“Similar results were found in an in vitro study [111], where the blood flow-induced mechanical forces determined arterial injury and promoted endothelial senescence via p53-p21cip1-dependent pathways [112].”
ResultVascular senescence in cardiovascular and metabolic diseases
Katsuumi, G., Shimizu, I., Yoshida, Y., & Minamino, T. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00018 · Cited by 196 · cited 1×
“There is evidence supporting that cellular senescence in the vascular system, named “vascular senescence”, is critically involved in the pathogenesis of cardiovascular and metabolic disorders [109].”
BackgroundThe Signaling of Cellular Senescence in Diabetic Nephropathy
Xiong, Y., & Zhou, L. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7495629 · Cited by 185 · cited 1×
“This form of senescence is also known as stress-induced premature senescence (SIPS) and has broad implications in health and diseases [8,9].”
BackgroundParacrine roles of cellular senescence in promoting tumourigenesis
Gonzalez-Meljem, J. M., Apps, J. R., Fraser, H. C., & Martinez-Barbera, J. P. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0066-1 · Cited by 183 · cited 1×
“The downside of this senescence-inducing approach is that senescent cells often align with malignant cells and support tumor expansion [104] as well as cancer initiation and progression [107].”
BackgroundCell cycle proliferation decisions: the impact of single cell analyses
Matson, J. P., & Cook, J. G. (2017) · The FEBS Journal · doi:10.1111/febs.13898 · Cited by 182 · cited 1×
“Upon physiological conditions, proliferating cells commit to a regular cell cycle [15,16].”
BackgroundGustafson, B., Nerstedt, A., & Smith, U. (2019) · Nature Communications · doi:10.1038/s41467-019-10688-x · Cited by 178 · cited 1×
“Obesity −/+ HFD Body weight phenotype and behavioral disorders; p53 represses the lipogenic Srebf1 pathway in Adipocytes [77,78]”
Backgroundp53-independent regulation of p21Waf1/Cip1 expression and senescence by Chk2.
Aliouat-Denis, C.-M., Dendouga, N., Van den Wyngaert, I., Goehlmann, H., Steller, U., van de Weyer, I., Van Slycken, N., Andries, L., Kass, S., Luyten, W., et al. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0121 · Cited by 177 · cited 1×
“reported that Chk2 was able to induce p-21Cip1 expression in p53-defective cell lines, contributing to Chk2-mediated senescence [49].”
BackgroundThe Regulation of Multiple p53 Stress Responses is Mediated through MDM2
Hu, W., Feng, Z., & Levine, A. J. (2012) · Genes & Cancer · doi:10.1177/1947601912454734 · Cited by 175 · cited 1×
“ATM/ATR, in turn, activate the p53/p21cip1 axis by phosphorylating both p53 and its ubiquitin ligase Mdm2, leading to the stabilization of p53 levels [25].”
Backgroundp53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration
Turnquist, C., Horikawa, I., Foran, E., Major, E. O., Vojtesek, B., Lane, D. P., Lu, X., Harris, B. T., & Harris, C. C. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.37 · Cited by 173 · cited 1×
“reported the expression of two isoforms of p53 in astrocytes, ∆133p53 and p53β; in in vitro primary human senescent astrocytes, a decreased expression of the isoform ∆133p53 was reported, and the decreased expression of this isoform, linked to neuroprotection, was attributed to autophagic degradation [127].”
BackgroundObesity and type-2 diabetes as inducers of premature cellular senescence and ageing
Burton, D. G. A., & Faragher, R. G. A. (2018) · Biogerontology · doi:10.1007/s10522-018-9763-7 · Cited by 173 · cited 1×
“Diabetes + hyperglycemia p53 contributes to insulin resistance; decreased islet proliferation [79,80]”
BackgroundmTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53
Jung, S. H., Hwang, H. J., Kang, D., Park, H. A., Lee, H. C., Jeong, D., Lee, K., Park, H. J., Ko, Y.-G., & Lee, J.-S. (2019) · Oncogene · doi:10.1038/s41388-018-0521-8 · Cited by 166 · cited 1×
“Many recent studies actually demonstrated how many OIS pathways can actually activate p53 bypassing the DDR: Ras through NOREA1, which promotes the pro-senescence acetylation of p53 while inhibiting its pro-apoptotic phosphorylation, AKT through the downregulation of MnSOD, onco-suppressor PTEN depletion, inducing mTO…”
BackgroundSpallarossa, P., Altieri, P., Aloi, C., Garibaldi, S., Barisione, C., Ghigliotti, G., Fugazza, G., Barsotti, A., & Brunelli, C. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00068.2009 · Cited by 160 · cited 1×
“More severe stimuli lead instead to apoptosis [36].”
BackgroundKuwano, K., Araya, J., Hara, H., Minagawa, S., Takasaka, N., Ito, S., Kobayashi, K., & Nakayama, K. (2016) · Respiratory Investigation · doi:10.1016/j.resinv.2016.03.010 · Cited by 153
p53 Mediates the Accelerated Onset of Senescence of Endothelial Progenitor Cells in Diabetes
Rosso, A., Balsamo, A., Gambino, R., Dentelli, P., Falcioni, R., Cassader, M., Pegoraro, L., Pagano, G., & Brizzi, M. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509293200 · Cited by 152 · cited 1×
“This was further confirmed by another study, in which depletion of endogenous p53 in EPC recovered from diabetic patients prevented the accelerated onset of senescence, indicating that a p53-mediated pathway contributes to the impaired EPC function in this setting [113].”
ResultDissecting Aging and Senescence—Current Concepts and Open Lessons
Schmeer, C., Kretz, A., Wengerodt, D., Stojiljkovic, M., & Witte, O. W. (2019) · Cells · doi:10.3390/cells8111446 · Cited by 144
Chen, J., Huang, X., Halicka, D., Brodsky, S., Avram, A., Eskander, J., Bloomgarden, N. A., Darzynkiewicz, Z., & Goligorsky, M. S. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00364.2005 · Cited by 142 · cited 1×
“The most extensively studied pathways involved in the regulation of cellular senescence are p53/p21cip1 and/or p16INK4A/Rb tumor suppressor pathways [29,30] (Figure 1).”
Backgroundp53 and the Carcinogenicity of Chronic Inflammation
Gudkov, A. V., & Komarova, E. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026161 · Cited by 132 · cited 1×
“For example, a significant number of p53-null mice die before tumor development from inflammation, resulting in abscesses, gastroenteritis, or myocarditis [122].”
BackgroundPoulsen, R. C., Watts, A. C., Murphy, R. J., Snelling, S. J., Carr, A. J., & Hulley, P. A. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203146 · Cited by 123 · cited 1×
“Inflammation Musculoskeletal pain + Glucocorticoids; Hsp90β Induction of irreversible senescence; Hsp90β/MDM2 induced p53-dependent senescence on muscle regeneration [93,94]”
BackgroundRadiation-induced astrocyte senescence is rescued by Δ133p53
Turnquist, C., Beck, J. A., Horikawa, I., Obiorah, I. E., Von Muhlinen, N., Vojtesek, B., Lane, D. P., Grunseich, C., Chahine, J. J., Ames, H. M., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz001 · Cited by 118 · cited 1×
“Brain cancer + TGFβ Acute activation of senescence in Glioblastomas [91,92]”
BackgroundAre there roles for brain cell senescence in aging and neurodegenerative disorders?
Tan, F. C. C., Hutchison, E. R., Eitan, E., & Mattson, M. P. (2014) · Biogerontology · doi:10.1007/s10522-014-9532-1 · Cited by 116 · cited 1×
“Other reports have linked senescence to the development of aging-related neurodegenerative diseases in human patients [125].”
BackgroundPathologies Associated with the p53 Response
Gudkov, A. V., & Komarova, E. A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001180 · Cited by 115 · cited 1×
“In this context, tissue specific differences can influence different p53 expression, contributing to the determination of the cell fate after exposure to genotoxic stress [74].”
BackgroundRole of p53 in the Regulation of the Inflammatory Tumor Microenvironment and Tumor Suppression
Uehara, I., & Tanaka, N. (2018) · Cancers · doi:10.3390/cancers10070219 · Cited by 115 · cited 2×
“Senescence induced in oncogene-expressing cells is a p53-dependent tumor-suppressor mechanism that prevents malignant transformation by suppressing cellular proliferation [121].”
BackgroundCellular senescence: a promising strategy for cancer therapy
Lee, S., & Lee, J.-S. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.1.294 · Cited by 115 · cited 4×
“Senescent cells regulate tumorigenesis and the immune response of their neighbors in both a positive and a negative manner via SASP and depending on the genetic context, thus limiting the application of this therapy [104].”
BackgroundInfluentialDDR-mediated crosstalk between DNA-damaged cells and their microenvironment
Malaquin, N., Carrier-Leclerc, A., Dessureault, M., & Rodier, F. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00094 · Cited by 113 · cited 1×
“DNA damage and /or DDR seem to critically control the two pathways [31,32].”
BackgroundTo clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · BioEssays · doi:10.1002/bies.201670910 · Cited by 108 · cited 1×
“p53 plays a pivotal role in determining the fate of the cells, and, in the context of senescence, its activation can take place in a DDR-dependent or DDR-independent way [22,23].”
Backgroundp53 Functions in Adipose Tissue Metabolism and Homeostasis
Krstic, J., Reinisch, I., Schupp, M., Schulz, T. J., & Prokesch, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092622 · Cited by 105
Regulation of senescence and the SASP by the transcription factor C/EBPβ
Salotti, J., & Johnson, P. F. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110752 · Cited by 103 · cited 2×
“Therefore, p53 might function as a restrictor and attenuator of inflammatory reactions via the balance between p53 and NF-kB.”
BackgroundIntihar, T. A., Martinez, E. A., & Gomez-Pastor, R. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00103 · Cited by 102 · cited 1×
“senescence involved in the striatum during HD development [85,86]”
BackgroundCellular Senescence and Iron Dyshomeostasis in Alzheimer’s Disease
Masaldan, S., Belaidi, A. A., Ayton, S., & Bush, A. I. (2019) · Pharmaceuticals · doi:10.3390/ph12020093 · Cited by 102 · cited 1×
“Alzheimer’s disease (AD) + Aβ (1-42) SIRT3 rescues neurons from p53 mediated senescence; Aβ (1-42) induces senescence [83,84]”
BackgroundThe TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1
Samarakoon, R., Higgins, S. P., Higgins, C. E., & Higgins, P. J. (2019) · Biomolecules · doi:10.3390/biom9080341 · Cited by 101 · cited 1×
“Cardiovascular metabolic disorders Cardiovascular injury + PAI-1; MEOX2 caveolin-1 Inhibits VSMCs grow and promote senescence; Meox protein play a role in p53-mediated endothelial disfunction [75,76]”
BackgroundEmerging roles of RB family: New defense mechanisms against tumor progression
Indovina, P., Marcelli, E., Casini, N., Rizzo, V., & Giordano, A. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24170 · Cited by 100 · cited 1×
“The p16 pathway can involve different proteins belonging to the Rb family, namely pRb/p105, p107, and pRb/p130 [55].”
BackgroundSelf-citationCellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics
Frey, N., Venturelli, S., Zender, L., & Bitzer, M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.146 · Cited by 97 · cited 1×
“The important role of the SASP inflammatory response in tumor prevention was demonstrated in mouse models for hepatocellular carcinoma (HCC), where induction of senescence by p53 activation in malignant hepatocytes was shown to reduce tumor size by SASP-mediated recruitment of immune cells to the tumors [120].”
Backgroundp53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes
Benson, E. K., Mungamuri, S. K., Attie, O., Kracikova, M., Sachidanandam, R., Manfredi, J. J., & Aaronson, S. A. (2014) · Oncogene · doi:10.1038/onc.2013.378 · Cited by 96 · cited 1×
“Once activated, p21cip1 performs many functions, including its role in mediating the gene expression modulation of many p53 targets such as CDC25C, CDC25B, and survivin, mainly through the E2F4 complex recruitment [45].”
BackgroundProbin, V., Wang, Y., Bai, A., & Zhou, D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107771 · Cited by 84 · cited 1×
“Regardless of the intensity, some stimuli seem to always trigger senescence; for example, busulfan, an alkylating agent, was proven to selectively induce senescence instead of apoptosis in WI38 fibroblasts [39].”
BackgroundLidzbarsky, G., Gutman, D., Shekhidem, H. A., Sharvit, L., & Atzmon, G. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00104 · Cited by 83
Martinez, L. A., Yang, J., Vazquez, E. S., del Carmen Rodriguez-Vargas, M., Olive, M., Hsieh, J.-T., Logothetis, C. J., & Navone, N. M. (2002) · Carcinogenesis · doi:10.1093/carcin/23.8.1289 · Cited by 80 · cited 1×
“treated prostate cancer cells with antisense p21cip1 adenovirus, this led to the development of apoptosis at lower doses [48].”
BackgroundShort-term gain, long-term pain: the senescence life cycle and cancer
Chan, A. S. L., & Narita, M. (2019) · Genes & Development · doi:10.1101/gad.320937.118 · Cited by 80 · cited 1×
“Cellular senescence has been implicated not only in aging itself but also in the onset of age-related disorders, including atherosclerosis, diabetes, and Alzheimer’s disease, in cancer, and, more recently, in biological processes such as tissue repair and regeneration and homeostasis of the microenvironment [72,73].”
BackgroundAutophagy role(s) in response to oncogenes and DNA replication stress
Vanzo, R., Bartkova, J., Merchut-Maya, J. M., Hall, A., Bouchal, J., Dyrskjøt, L., Frankel, L. B., Gorgoulis, V., Maya-Mendoza, A., Jäättelä, M., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0403-9 · Cited by 79 · cited 1×
“Stressors include both intrinsic factors, such as oxidative damage, telomere attrition, hyperproliferation, oncogene activation, and environmental sources, including UV-light, γ-irradiation, and chemotherapeutic drugs [18,19].”
BackgroundA p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation
Valentine, J. M., Kumar, S., & Moumen, A. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-79 · Cited by 77 · cited 1×
“p53 plays a pivotal role in determining the fate of the cells, and, in the context of senescence, its activation can take place in a DDR-dependent or DDR-independent way [22,23].”
BackgroundRas-Induced Senescence and its Physiological Relevance in Cancer
DiMauro, T., & David, G. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910793357998 · Cited by 76 · cited 1×
“Increased expression of the inflammatory regulators has been observed in primary human diploid fibroblasts induced to undergo senescence by oncogenic ras (HrasV12) [117].”
BackgroundGalderisi, U., Helmbold, H., Squillaro, T., Alessio, N., Komm, N., Khadang, B., Cipollaro, M., Bohn, W., & Giordano, A. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0324 · Cited by 76 · cited 1×
“The activation of the p53 pathway and the consequent cell cycle arrest context seem to be responsible for this shift, inducing the decrease in the levels of p105 and p107 and the increase in the levels of p130 in its hyperphosphorylated form, thus the proposal of p130 as a more specific senescence marker [57].”
BackgroundSelf-citationMária, J., & Ingrid, Ž. (2017) · Food & Function · doi:10.1039/c7fo00161d · Cited by 71 · cited 1×
“Characteristic alterations of senescent cells include flattened and enlarged cell shape, expanded lysosomal compartment and vacuoles, increased metabolic rate and reactive oxygen species (ROS) production, senescence-associated secretory phenotype (SASP) secretion, nuclear and chromatin alterations, and resistance to a…”
BackgroundPawlikowski, J. S., Adams, P. D., & Nelson, D. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.109728 · Cited by 70 · cited 1×
“The concept of cellular senescence was initially introduced several decades ago by Leonard Hayflick [1].”
BackgroundHelmbold, H., Komm, N., Deppert, W., & Bohn, W. (2009) · Oncogene · doi:10.1038/onc.2009.222 · Cited by 68 · cited 1×
“According to these findings, the activation of p16 pathway would be responsible for drawing a line between two different phases of senescence: an early, reversible phase dominated by p53 activity and an irreversible phase induced by p16/Rb pathway [54].”
BackgroundChromosomal instability-induced senescence potentiates cell non-autonomous tumourigenic effects
He, Q., Au, B., Kulkarni, M., Shen, Y., Lim, K. J., Maimaiti, J., Wong, C. K., Luijten, M. N. H., Chong, H. C., Lim, E. H., et al. (2018) · Oncogenesis · doi:10.1038/s41389-018-0072-4 · Cited by 68 · cited 1×
“Loss of p53 function promotes (directly and indirectly) chromosomal instability, inducing cells to enter either senescence or apoptosis [13].”
BackgroundGiménez‐Bastida, J. A., Ávila‐Gálvez, M. Á., Espín, J. C., & González‐Sarrías, A. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900629 · Cited by 68 · cited 1×
“Cancer/ tumors Breast cancer + RSV; Kindlin-2 RSV metabolites induce senescence in breast cancer cells [87,88]”
BackgroundCellular senescence regulated by SWI/SNF complex subunits through p53/p21 and p16/pRB pathway
He, L., Chen, Y., Feng, J., Sun, W., Li, S., Ou, M., & Tang, L. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.07.007 · Cited by 67 · cited 1×
“Primary senescence Induction of p53/p21 pathway, induction of antiproliferative transcriptional program BAF57, GADD45 NOTCH1/N1ICD, p21 [62,69]”
BackgroundDolan, D., Županič, A., Nelson, G., Philip, H., Miwa, S., Kirkwood, T. B. L., & Shanley, D. P. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004246 · Cited by 64 · cited 1×
“This was suggested by the observation of a decrease in p53 levels after induction of senescence, while p16 levels stayed steadily high [52].”
BackgroundZhang, Y., Gao, Y., Zhang, G., Huang, S., Dong, Z., Kong, C., Su, D., Du, J., Zhu, S., Liang, Q., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25365 · Cited by 64 · cited 1×
“, who demonstrated how, in response to high levels of doxorubicin, p53 inhibits p21cip1 expression through DNMT3a in colorectal cancer cells [47].”
BackgroundAli, A., Abedini, M. R., & Tsang, B. K. (2011) · Oncogene · doi:10.1038/onc.2011.399 · Cited by 64 · cited 1×
“P53 is directly phosphorylated in Ser-15 and indirectly phosphorylated in Ser-20 via Chk1/2 [26].”
BackgroundGu, C., Li, Y., Liu, J., Ying, X., Liu, Y., Yan, J., Chen, C., Zhou, H., Cao, L., & Ma, Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6367 · Cited by 64 · cited 4×
“Abbreviation: PAI-1: plasminogen activator inhibitor-1; Meox2: mesenchyme homeobox 2; HFD: High Fat Diet; Srebf1: Sterol Regulatory Element-Binding transcription factor1; MPTP: 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine; CAG144 R6/2: transgenic mice model human Huntington’s disease (HD); RSV: resveratrol; WASp: the W…”
BackgroundInfluentialWhen the guardian sleeps: Reactivation of the p53 pathway in cancer
Merkel, O., Taylor, N., Prutsch, N., Staber, P. B., Moriggl, R., Turner, S. D., & Kenner, L. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2017.02.003 · Cited by 63 · cited 1×
“In most cases, therapies aimed at reactivation of p53 will be part of a combined therapy in which the biggest challenge will be finding the best therapeutic partner in relation to the specific tumor type and the molecular status of p53 [106].”
BackgroundSenescence and cancer: An evolving inflammatory paradox
Ruhland, M. K., Coussens, L. M., & Stewart, S. A. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.10.001 · Cited by 60 · cited 1×
“The connection between inflammation and cellular senescence was initially suggested by studies on the gene expression profiles of senescent cells, where inflammatory responses were associated with wound healing processes [116].”
Backgroundp53 Isoforms in Cellular Senescence- and Ageing-Associated Biological and Physiological Functions
Fujita, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236023 · Cited by 56 · cited 2×
“Moreover, Δ40p53 seems to regulate cellular senescence and aging by acting in two different ways: by directly regulating the IGF-1 signaling pathway to modulate cell growth and survival factors and by regulating the transcriptional activity of full-length p53 on target gene through direct binding of p53 full-length [4…”
Backgroundp53 in Bronchial Club Cells Facilitates Chronic Lung Inflammation by Promoting Senescence
Sagiv, A., Bar-Shai, A., Levi, N., Hatzav, M., Zada, L., Ovadya, Y., Roitman, L., Manella, G., Regev, O., Majewska, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.009 · Cited by 55
Sundar, I. K., Rashid, K., Gerloff, J., Li, D., & Rahman, I. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0390oc · Cited by 53
MIN, E.-Y., KIM, I.-H., LEE, J., KIM, E.-Y., CHOI, Y.-H., & NAM, T.-J. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2426 · Cited by 51 · cited 1×
“Moreover, p21CIP1 protein levels may lead to the inhibition of Cdk4/6 activity, which contribute to the G1 arrest or senescence [33,34].”
BackgroundUnfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link?
Stanga, S., Lanni, C., Govoni, S., Uberti, D., D'Orazi, G., & Racchi, M. (2010) · Aging · doi:10.18632/aging.100205 · Cited by 51 · cited 1×
“Alzheimer’s disease (AD) + Aβ (1-42) SIRT3 rescues neurons from p53 mediated senescence; Aβ (1-42) induces senescence [83,84]”
BackgroundCooperation between p53 and p130(Rb2) in induction of cellular senescence
Kapic, A., Helmbold, H., Reimer, R. A., Klotzsche, O., Deppert, W., & Bohn, W. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401756 · Cited by 50 · cited 1×
“In fact, the crosstalk between p53 and pRb demonstrated that, when p53 and pRb were restored concomitantly to normal levels in human cervix carcinoma cells, cellular senescence was induced in nearly all of the cells [59].”
BackgroundHobson, S., Arefin, S., Kublickiene, K. R., Shiels, P. G., & Stenvinkel, P. (2019) · Toxins · doi:10.3390/toxins11020082 · Cited by 49 · cited 1×
“Moreover, p21CIP1 protein levels may lead to the inhibition of Cdk4/6 activity, which contribute to the G1 arrest or senescence [33,34].”
BackgroundQi, X., Davis, B., Chiang, Y., Filichia, E., Barnett, A., Greig, N. H., Hoffer, B., & Luo, Y. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13706 · Cited by 49
ITGB 4 deficiency induces senescence of airway epithelial cells through p53 activation
Yuan, L., Du, X., Tang, S., Wu, S., Wang, L., Xiang, Y., Qu, X., Liu, H., Qin, X., & Liu, C. (2019) · FEBS Journal · doi:10.1111/febs.14749 · Cited by 47 · cited 1×
“Asthma/bronchitis + LPS; TNF-α cell senescence promotes chronic lung inflammation; downregulation of ITGB4 induces senescence in inflammation [95,96]”
BackgroundHsp90β interacts with MDM2 to suppress p53‐dependent senescence during skeletal muscle regeneration
He, M. Y., Xu, S. B., Qu, Z. H., Guo, Y. M., Liu, X. C., Cong, X. X., Wang, J. F., Low, B. C., Li, L., Wu, Q., et al. (2019) · Aging Cell · doi:10.1111/acel.13003 · Cited by 45 · cited 1×
“Inflammation Musculoskeletal pain + Glucocorticoids; Hsp90β Induction of irreversible senescence; Hsp90β/MDM2 induced p53-dependent senescence on muscle regeneration [93,94]”
BackgroundInflammatory signaling in genomically instable cancers
Talens, F., & van Vugt, M. A. T. M. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1638192 · Cited by 43 · cited 1×
“In the first case, telomere erosion, DNA damage, as well as hyperactivation of oncogenes and inactivation of onco-suppressors (oncogene induced senescence, OIS) resulting from replicative stress activate the DNA damage repair cascade [24].”
BackgroundAlessio, N., Capasso, S., Ferone, A., Di Bernardo, G., Cipollaro, M., Casale, F., Peluso, G., Giordano, A., & Galderisi, U. (2017) · Neoplasia · doi:10.1016/j.neo.2017.06.005 · Cited by 42 · cited 2×
“However, in the progression of senescence in human cells, a primary role seems to be held by Rb2/p130 through the cyclin A repression, with the classic Rb involved just in the early phases [56].”
BackgroundSelf-citationHo, D. H., Seol, W., & Son, I. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1577666 · Cited by 39
The Kindlin2-p53-SerpinB2 signaling axis is required for cellular senescence in breast cancer
Sossey‐Alaoui, K., Pluskota, E., Szpak, D., & Plow, E. F. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1774-z · Cited by 38 · cited 1×
“Cancer/ tumors Breast cancer + RSV; Kindlin-2 RSV metabolites induce senescence in breast cancer cells [87,88]”
BackgroundCarracedo, J., Alique, M., Ramírez-Carracedo, R., Bodega, G., & Ramírez, R. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666180820115726 · Cited by 36 · cited 1×
“However, senescent endothelial cells change their morphological and functional characteristics and cannot correctly regulate repairing and regenerative activities of endothelial progenitor cells (EPCs) [110].”
BackgroundIs cellular senescence involved in cystic fibrosis?
Bezzerri, V., Piacenza, F., Caporelli, N., Malavolta, M., Provinciali, M., & Cipolli, M. (2019) · Respiratory Research · doi:10.1186/s12931-019-0993-2 · Cited by 34 · cited 1×
“In most of the models studying senescent cells, p53 (as well as the DDR proteins) seems to be involved in the earlier stages, and the time factor plays an important role in the entire process [67].”
BackgroundInduction of senescence in primary glioblastoma cells by serum and TGFβ
Kumar, R., Gont, A., Perkins, T. J., Hanson, J. E. L., & Lorimer, I. A. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-02380-1 · Cited by 28
Cellular Senescence in Chronic Obstructive Pulmonary Disease: Multifaceted and Multifunctional
Antony, V. B., & Thannickal, V. J. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0061ed · Cited by 27 · cited 5×
“However, cellular senescence may still contribute to disease susceptibility, age at disease presentation, and rate of progression [118].”
BackgroundInfluentialVascular senescence and ageing: a role for the MEOX proteins in promoting endothelial dysfunction
Northcott, J. M., Czubryt, M. P., & Wigle, J. T. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2017-0149 · Cited by 25
A dynamical systems model for the measurement of cellular senescence
Galvis, D., Walsh, D. A., Harries, L. W., Latorre, E., & Rankin, J. (2019) · Journal of The Royal Society Interface · doi:10.1098/rsif.2019.0311 · Cited by 25 · cited 1×
“Developing senescence p53/p21 and/or p16 pathway, SASP release, Morphological changes p21, P19, p16, LIMA1, Ki-67 [70,71]”
The persistent dynamic secrets of senescence
Schmitt, C. A. (2016) · Nature Cell Biology · doi:10.1038/ncb3403 · Cited by 18 · cited 1×
“Developing senescence p53/p21 and/or p16 pathway, SASP release, Morphological changes p21, P19, p16, LIMA1, Ki-67 [70,71]”
Li, H., Petersen, S., Mariscal, A. G., & Brakebusch, C. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-1253 · Cited by 18 · cited 1×
“Skin Tumor + N-WASP; Doxycycline N-WASP is a negative regulator of senescence induction by p53 [89,90]”
BackgroundEffects of p21 deletion in mouse models of premature aging
Benson, E. K., Zhao, B., Sassoon, D. A., Lee, S. W., & Aaronson, S. A. (2009) · Cell Cycle · doi:10.4161/cc.8.13.8997 · Cited by 14 · cited 1×
“Atm−/− p21 cip1−/− mice, similarly to Atm−/− mice with deleted p53, are not more susceptible to tumors and exhibit a delayed onset of lymphomas, presumably due to increased lymphoid cell apoptosis, suggesting that p21cip1 is a critical participant in p53-dependent senescence pathways [50].”
BackgroundFenofibrate triggers apoptosis of glioblastoma cells in vitro
Giordano, A., & Macaluso, M. (2012) · Cell Cycle · doi:10.4161/cc.21719 · Cited by 9 · cited 1×
“Regardless of their origin, the stress factors trigger DNA damage responses (DDR) in the affected cells, which can result in different outcomes, depending on the cell type and the extent of the damage [20].”
BackgroundSelf-citationSenescence regulation by nuclear N-WASP: a role in cancer?
Li, H., & Brakebusch, C. (2019) · Oncoscience · doi:10.18632/oncoscience.487 · Cited by 7
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
“p16INK4A inactivates Cdk4/6, phosphorylates Rb accumulation and inactivates E2F transcription, leading to cell cycle arrest or senescence.(85) Alternatively, when UV-induced DNA damage occurs, ATM/ATR activates Chk1/Chk2 kinase, which further activates p53 and p21, leading to G1 arrest or senescence.”
BackgroundTargeting cellular senescence with senotherapeutics: senolytics and senomorphics
Zhang, L., Pitcher, L. E., Prahalad, V., Niedernhofer, L. J., & Robbins, P. D. (2023) · The FEBS Journal · doi:10.1111/febs.16350 · Cited by 621
p53 signaling in cancer progression and therapy
Marei, H. E., Althani, A., Afifi, N., Hasan, A., Caceci, T., Pozzoli, G., Morrione, A., Giordano, A., & Cenciarelli, C. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02396-8 · Cited by 588
Self-citationFerroptosis, radiotherapy, and combination therapeutic strategies
Lei, G., Mao, C., Yan, Y., Zhuang, L., & Gan, B. (2021) · Protein & Cell · doi:10.1007/s13238-021-00841-y · Cited by 504
ROS: Basic Concepts, Sources, Cellular Signaling, and its Implications in Aging Pathways
de Almeida, A. J. P. O., de Oliveira, J. C. P. L., da Silva Pontes, L. V., de Souza Júnior, J. F., Gonçalves, T. A. F., Dantas, S. H., de Almeida Feitosa, M. S., Silva, A. O., & de Medeiros, I. A. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1225578 · Cited by 474
“Oxidative stress can induce DDR directly or indirectly by several pathways and, consequently, the activation of p53/p21 and p16/pRB pathways [288].”
Background
Metadata
- Authors
- Mijit, M., Caracciolo, V., Melillo, A., Amicarelli, F., & Giordano, A.
- Affiliations
- University of Siena (IT)
- Temple University (US)
- University of L'Aquila (IT)
- Corresponding author
- Giordano, Antonio
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2020-03-08
- Volume
- 10
- Issue
- 3
- Pages
- 420
- ISSN
- 2218-273X (ISSN-L)
- PMC
- PMC7175209
- OpenAlex
- W3010215457
- Cited by
- 639
- References
- 128
- Citations by year
- 2026: 100 · 2025: 142 · 2024: 126 · 2023: 96 · 2022: 92 · 2021: 64 · 2020: 17
- FWCI
- 8.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomolecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- TUScholarShare (Temple University) (submittedVersion, cc-by)
- UniTERAMO Research Catalog (University of Teramo) (submittedVersion, other-oa)
- Use Siena air (University of Siena) (submittedVersion, other-oa)
- Funders
- H2020 Marie Skłodowska-Curie Actions (713714)
- Commonwealth of Pennsylvania, Department of Health (290228/13650)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- p53, cellular senescence, DNA damage response, cell cycle arrest, apoptosis, genome stability, aging, antitumor immunity, senescence-associated secretory phenotype, inflammatory cytokines, tumor microenvironment, tissue dysfunction
- MeSH terms
- Animals, DNA Damage, DNA Repair, Humans, Tumor Suppressor Protein p53, Cellular Senescence, Cell Cycle Checkpoints, Cellular Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.